Jeffrey Glassberg
Interim Vice Chair of Research · Icahn School of Medicine at Mount Sinai
Credentials: · · · ·
History
- Present
Research · Icahn School of Medicine at Mount Sinai
2006–2009
Research
Blood Advances · 2020 · 358 citations
Emergency provider analgesic practices and attitudes toward patients with sickle cell disease
Annals of Emergency Medicine · 2013 · First of 7 authors · Corresponding · 87 citations
Clinical predictors of poor outcomes in patients with sickle cell disease and COVID-19 infection
Blood Advances · 2021 · 59 citations
20 papers
18 papers
17 papers
14 papers
- JK
11 papers
9 papers · 3 as a resident
8 papers
8 papers
Grants
- 2023–2028
"REAL Answers" (Registry Expansion Analyses to Learn)
National Heart, Lung, and Blood Institute · U01
Contact PI · $9.7M · Icahn School of Medicine at Mount Sinai
- 2022–2027
SCD REVIVE - Retina to Evaluate Vaso Occlusion In the Vasculature of the Eye
National Heart, Lung, and Blood Institute · R01
Contact PI · $4M · Icahn School of Medicine at Mount Sinai
- 2018–2024
IMPROVE 2: Inhaled Mometasone to Promote Reduction in Vaso-Occlusive Events
National Heart, Lung, and Blood Institute · R01
Contact PI · $4.1M · Icahn School of Medicine at Mount Sinai
- 2013–2018
Inhaled Mometasone to Promote Reduction in Vaso-Occlusive Events (IMPROVE)
National Heart, Lung, and Blood Institute · K23
Contact PI · $856.9K · Icahn School of Medicine at Mount Sinai
Clinical trials
- 2018–2023
Inhaled Mometasone to Promote Reduction in Vasoocclusive Events 2
Principal investigator · Completed · Phase 2
Jeffrey Glassberg
- 2014–2017
Inhaled Mometasone to Reduce Painful Episodes in Patients With Sickle Cell Disease
Principal investigator · Completed · Phase 2
Jeffrey Glassberg
- 2010–2013
Regional Anesthesia for Sickle Cell Crisis Using Ultrasound in The Emergency Department: Phase I
Principal investigator · Terminated · Phase 1
Icahn School of Medicine at Mount Sinai